20/02/2025
|
07:00
|
Final Results
|
RNS
|
12/02/2025
|
07:00
|
Delayed FDA Approval of SUBLOCADE Label Changes
|
RNS
|
04/02/2025
|
15:12
|
Notice of Results
|
RNS
|
04/02/2025
|
07:00
|
Completion of Share Repurchase Program
|
RNS
|
04/02/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
03/02/2025
|
09:26
|
Total Voting Rights
|
RNS
|
03/02/2025
|
07:00
|
Appointment of Independent Non-Executive Director
|
RNS
|
28/01/2025
|
15:30
|
Dr. David Wheadon appointed Chair of the Board
|
RNS
|
28/01/2025
|
09:43
|
Holding(s) in Company
|
RNS
|
28/01/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
27/01/2025
|
09:08
|
Holding(s) in Company
|
RNS
|
21/01/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
16/01/2025
|
16:00
|
Replacement Transaction in Own Shares
|
RNS
|
14/01/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
09/01/2025
|
13:00
|
Indivior Provides Historical Financials in US GAAP
|
RNS
|
07/01/2025
|
08:55
|
Holding(s) in Company
|
RNS
|
07/01/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
02/01/2025
|
09:31
|
Total Voting Rights
|
RNS
|
31/12/2024
|
09:53
|
Holding(s) in Company
|
RNS
|
31/12/2024
|
07:00
|
Transaction in Own Shares
|
RNS
|
24/12/2024
|
07:00
|
Transaction in Own Shares
|
RNS
|
23/12/2024
|
10:32
|
Director/PDMR Shareholding
|
RNS
|
17/12/2024
|
07:00
|
Indivior Announces Changes to Board of Directors
|
RNS
|
17/12/2024
|
07:00
|
Transaction in Own Shares
|
RNS
|
10/12/2024
|
07:00
|
Transaction in Own Shares
|
RNS
|
03/12/2024
|
07:00
|
Transaction in Own Shares
|
RNS
|
02/12/2024
|
09:44
|
Total Voting Rights
|
RNS
|
26/11/2024
|
07:00
|
Transaction in Own Shares
|
RNS
|
22/11/2024
|
07:00
|
Indivior to Participate in Upcoming Investor Event
|
RNS
|
19/11/2024
|
07:00
|
Transaction in Own Shares
|
RNS
|
18/11/2024
|
08:48
|
Holding(s) in Company
|
RNS
|
15/11/2024
|
07:00
|
Director Declaration
|
RNS
|
12/11/2024
|
07:00
|
Transaction in Own Shares
|
RNS
|
11/11/2024
|
14:29
|
Holding(s) in Company
|
RNS
|
08/11/2024
|
16:50
|
Block listing Interim Review
|
RNS
|
08/11/2024
|
07:00
|
Indivior Responds to Letter from Oaktree
|
RNS
|
05/11/2024
|
07:00
|
Indivior Completes Refinance of Secured Term Loan
|
RNS
|
05/11/2024
|
07:00
|
Transaction in Own Shares
|
RNS
|
01/11/2024
|
11:59
|
Total Voting Rights
|
RNS
|
29/10/2024
|
07:00
|
Transaction in Own Shares
|
RNS
|
24/10/2024
|
07:00
|
3rd Quarter Results
|
RNS
|
22/10/2024
|
07:00
|
Transaction in Own Shares
|
RNS
|
15/10/2024
|
07:00
|
Transaction in Own Shares
|
RNS
|
15/10/2024
|
07:00
|
Notice of Results
|
RNS
|
10/10/2024
|
12:00
|
Preliminary Q3 Results & Updated FY 2024 Guidance
|
RNS
|
08/10/2024
|
07:00
|
Transaction in Own Shares
|
RNS
|
03/10/2024
|
14:30
|
Chair Succession Plan
|
RNS
|
01/10/2024
|
07:58
|
Total Voting Rights
|
RNS
|
01/10/2024
|
07:00
|
Transaction in Own Shares
|
RNS
|
24/09/2024
|
07:00
|
Transaction in Own Shares
|
RNS
|